Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer than half of patients. Now, a new study identifies a panel of genetic markers that predicted which ...
Mar 30, 2015
0
9
Prostate cancer is the most commonly diagnosed cancer in men. But it can be difficult to diagnose, and it’s hard to know which cancers will become dangerous and which need less-aggressive treatment. Researchers and clinicians ...
May 23, 2011
0
1
The dog may be man's best friend but even so it comes as a surprise that the two species share a common tumor marker. This finding comes from a joint study between scientists of the Vetmeduni Vienna and the MedUni Wien. The ...
Apr 18, 2011
0
0
New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein ...
Aug 15, 2012
0
0
Scientists have discovered that cervical cancer can be divided into two distinct molecular subgroups—one far more aggressive than the other—as part of the largest "omics" study of its kind, led by researchers at UCL and ...
Oct 21, 2022
0
53
A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better response for patients with a specific biological marker, a team led by scientists at The University ...
May 31, 2011
0
0
In a proof-of-concept study, an international scientific team led by Johns Hopkins Kimmel Cancer Center researchers has shown that a laboratory test using artificial intelligence tools has the potential to more accurately ...
Jul 17, 2019
0
85
Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will ...
Mar 22, 2012
0
0
Using two cell surface markers found to be highly expressed in breast cancer lymph node metastases, researchers at Moffitt Cancer Center, working with colleagues at other institutions, have developed targeted, fluorescent ...
Jan 12, 2012
0
0
Ovarian cancer is a major health concern for women and the identification of sensitive biomarkers for early detection and/or monitoring of disease recurrence is of high clinical relevance.
Dec 7, 2011
0
0
